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Background
•
•
•
•
•
•

Ovarian Cancer is the fifth leading cause of cancer related death in women and affects around 22,000 women each year
(American Cancer Society, 2018).
Ovarian cancer is estimated to claim 13,980 lives in 2019 alone (American Cancer society, 2018).
Survival rate is between 17%-39% due to prognosis occurring in the later stages of the disease

Possible Conclusion

NK ( Natural Killer) cells are the cells that ID as well as kill tumor cells and are usually the first responders in these matters but
short lived.
Tumor cells have grown to be efficient in avoiding detection from innate immune cells
NK cells will be given more time by taking telomerase from HeLa cells and placed in NK cells, increasing their efficiency in
detecting, Identifying and killing tumor cells through increasing their lifespan

Figure1. Bioluminescent imaging displaying tumor size before and after injection with tumor cells.
B Liao, John & J Ovenell, Kelsie & E M Curtis, Erin & Cecil, Denise & R Koehnlein, Marlese & Rastetter, Lauren & Gad, Ekram & L Disis, Mary. (2015). Preservation of tumor-host immune interactions with luciferase-tagged imaging in a

murine model of ovarian cancer. Journal for Immunotherapy of Cancer. 3. 10.1186/s40425-015-0060-6.

Specific Aim
In order to improve the innate response in the immune system to recognize,
elongate and increase anti-tumor responses in ovarian cancer patients, telomerase
derived form (from)HeLa cells will be introduced into NK cells to increase their lifespan
and efficacy in killing cancer cells associated with ovarian cancers.They will then be
Figure 2. Log scales containing the mean volume of tumors at five different doses displayed on box plots . Heitjan DF, Manni A, Santen RJ. Statistical analysis of in vivo tumor

treated with a TK1- suicide gene in order to control NK cells activity. Pro-apoptotic
activity will be measured to determine efficacy of treatment.

Proposed Methods

growth experiments. Cancer Res1993;53:6042–50.

• Through Bioluminescent Imagining, it is expected to observe a
decrease in tumor size in mice treated with modified NK cells
• Through MANOVA analysis, pro-apoptotic activity is expected to

HeLa cells will be obtained and murine NK cells will then be
isolated from the spleen of rodents by way of monoclonal
antibodies and magnetic separation.

show increase in mice treated with modified NK cells in comparison
to mice that did not receive treatment with transformed cells

Potential Pitfalls
The NK cells will be transfected with both hTRT1 and hTRT2 to
increase efficacy and the inducted with HeLa derived
telomerase

• The modified NK cells made to improve efficacy in tumor destruction will in turn
become cancerous.
• The telomerase that derived from HeLa cells failed to be successfully integrated
within the NK cell, resulting in the lifespan of the cell remaining unchanged.

NK cells that have been transfected with the TK1- suicide gene
will be injected into the ID8 mouse ovarian model surface cells
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